Login to Your Account

Big Pharma Mega-Mergers Now, But Biotech M&A Still on Tap

By Jennifer Boggs

Monday, March 16, 2009
The long-predicted wave of consolidation in the drug development industry could finally come rolling in this year, if the last two months are any indication, with Pfizer Inc. offering $68 billion for Wyeth, Merck & Co. Inc. merging with Schering-Plough Corp. in a $41.1 billion deal and Roche Holdings AG's $46.8 billion offer for the remaining minority stake of Genentech Inc.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription